Drug Resistance in Non-B Subtype HIV-1: Impact of HIV-1 Reverse Transcriptase Inhibitors

Drug Resistance in Non-B Subtype HIV-1: Impact of HIV-1 Reverse Transcriptase Inhibitors

Human immunodeficiency virus (HIV) causes approximately 2.5 million new infections every year, and nearly 1.6 million patients succumb to HIV each year. Several factors, including cross-species transmission and error-prone replication have resulted in extraordinary genetic diversity of HIV groups. O...

Full description

Bibliographic Details
Main Authors: Kamalendra Singh, Jacqueline A. Flores, Karen A. Kirby, Ujjwal Neogi, Anders Sonnerborg, Atsuko Hachiya, Kalyan Das, Eddy Arnold, Carole McArthur, Michael Parniak, Stefan G. Sarafianos
Format: Article
Language:English
Published: MDPI AG 2014-09-01
Series:Viruses
Subjects:
HIV-1 reverse transcriptase
HIV subtypes
nucleoside RT inhibitors
non-nucleoside RT inhibitors
translocation defective RT inhibitors
drug resistance
Online Access:http://www.mdpi.com/1999-4915/6/9/3535

Internet

http://www.mdpi.com/1999-4915/6/9/3535

Similar Items